Merrimack Pharmaceuticals, Inc. MACK

Buy buy buy before it’s to late buy and hold ???????????????

US)
15.000
14.880
+7.22%
-0.80%

By Sabela Ojea

Merrimack Pharmaceuticals said it will receive a $225 million milestone payment from Ipsen after the U.S. Food and Drug Administration approved the supplemental new drug application for its pancreatic cancer treatment Onivydee.

The biopharmaceutical company on Tuesday said the payment is due on or before March 29.

The company has received several payments from Ipsen in the past, including a $575 million payment in 2017.

Sooon $HYLN

$MACK BOOM!!! ???

Sold my calls hope my puts play out next week

$MACK - Down to 5.50 end of day. 4.30 by next Monday. This is absolutely pumped to be dumped!

This will crack! Good luck you bulls!